These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 32147066)

  • 1. Review/overview of pain in sickle cell disease.
    Ballas SK; Darbari DS
    Complement Ther Med; 2020 Mar; 49():102327. PubMed ID: 32147066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids and Sickle Cell Disease: From Opium to the Opioid Epidemic.
    Ballas SK
    J Clin Med; 2021 Jan; 10(3):. PubMed ID: 33498726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the Treatment of Sickle Cell Disease.
    Kapoor S; Little JA; Pecker LH
    Mayo Clin Proc; 2018 Dec; 93(12):1810-1824. PubMed ID: 30414734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red Blood Cells as Therapeutic Target to Treat Sickle Cell Disease.
    Bhatt S; Argueta DA; Gupta K; Kundu S
    Antioxid Redox Signal; 2024 Jun; 40(16-18):1025-1049. PubMed ID: 37975291
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute and chronic pain management in patients with sickle cell disease in the modern era: a comprehensive review.
    Tolu SS; Van Doren L
    Transfus Apher Sci; 2022 Oct; 61(5):103533. PubMed ID: 36058780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting novel mechanisms of pain in sickle cell disease.
    Tran H; Gupta M; Gupta K
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):546-555. PubMed ID: 29222304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Review of Crizanlizumab: A New Parenteral Option to Reduce Vaso-occlusive Pain Crises in Patients with Sickle Cell Disease.
    Han J; Saraf SL; Gordeuk VR
    Pharmacotherapy; 2020 Jun; 40(6):535-543. PubMed ID: 32350885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute kidney injury during a pediatric sickle cell vaso-occlusive pain crisis.
    Baddam S; Aban I; Hilliard L; Howard T; Askenazi D; Lebensburger JD
    Pediatr Nephrol; 2017 Aug; 32(8):1451-1456. PubMed ID: 28238158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease.
    Puri L; Nottage KA; Hankins JS; Anghelescu DL
    Paediatr Drugs; 2018 Feb; 20(1):29-42. PubMed ID: 28853040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidities in aging patients with sickle cell disease.
    Ballas SK
    Clin Hemorheol Microcirc; 2018; 68(2-3):129-145. PubMed ID: 29614628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sickle cell disease in the emergency department.
    Lovett PB; Sule HP; Lopez BL
    Emerg Med Clin North Am; 2014 Aug; 32(3):629-47. PubMed ID: 25060254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative approaches to treating pain in sickle cell disease: Pre-clinical and clinical evidence.
    Sagi V; Argueta DA; Kiven S; Gupta K
    Complement Ther Med; 2020 Jun; 51():102394. PubMed ID: 32507420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging pharmacotherapeutic approaches for the management of sickle cell disease.
    Torres L; Conran N
    Expert Opin Pharmacother; 2019 Feb; 20(2):173-186. PubMed ID: 30499731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New and emerging treatments for vaso-occlusive pain in sickle cell disease.
    Dampier C
    Expert Rev Hematol; 2019 Oct; 12(10):857-872. PubMed ID: 31364883
    [No Abstract]   [Full Text] [Related]  

  • 15. Sickle Cell Disease in the Emergency Department.
    Lovett PB; Sule HP; Lopez BL
    Hematol Oncol Clin North Am; 2017 Dec; 31(6):1061-1079. PubMed ID: 29078924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An innovative intervention for the prevention of vaso-occlusive episodes in sickle cell disease.
    Jeon WJ; Joung B; Moon JH; Hino C; Park D; Pham B; Castillo DR; Chong E; Kaur S; Grismore C; Cao H
    Hematology; 2023 Dec; 28(1):2215575. PubMed ID: 37227254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse Models of Pain in Sickle Cell Disease.
    Sagi V; Song-Naba WL; Benson BA; Joshi SS; Gupta K
    Curr Protoc Neurosci; 2018 Oct; 85(1):e54. PubMed ID: 30265442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update review of new therapies in sickle cell disease: the prospects for drug combinations.
    Lugthart S; Ginete C; Kuona P; Brito M; Inusa BPD
    Expert Opin Pharmacother; 2024 Feb; 25(2):157-170. PubMed ID: 38344818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting novel mechanisms of pain in sickle cell disease.
    Tran H; Gupta M; Gupta K
    Blood; 2017 Nov; 130(22):2377-2385. PubMed ID: 29187376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sickle Cell Disease: A Brief Update.
    Azar S; Wong TE
    Med Clin North Am; 2017 Mar; 101(2):375-393. PubMed ID: 28189177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.